Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

28. Avril 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2992


	Articles 1 - 20 / 59834

	Impact of South Korea's national gastrointestinal cancer screening programme on incidence and mortality: a population-based difference-in-differences study. BMJ Open Cha J, Kang M. PMID: 42044968 [PubMed - indexed for MEDLINE]
	Correction: UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL family. Mol Biomed Zhang M, Li J, Liu S, Zhou F, Zhang L. PMID: 42043492 [PubMed - in process]
	Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey. Curr Oncol Bayram S, Köylü B, M, Alemdar MS, Yerlikaya T, Selçukbiricik F, Bilici A, Tatli AM, Ozdogan M. PMID: 42041735 [PubMed - indexed for MEDLINE]
	Epigenetic mechanisms linking hexavalent chromium exposure to pancreatic cancer risk: a systematic review. Environ Epigenet Hayashi K, Huang Y, Muir KR, Lophatananon A. PMID: 42039696 [PubMed]
	Radiomics-Driven Machine Learning Models for Diagnosis of Pancreatic Adenocarcinoma. Iran J Med Sci Talebi A, Akhavan Moghadam J, Sepandi M, Chatab Mohammadi T, Rahmatizadeh A, Shankayi Z. PMID: 42039224 [PubMed - indexed for MEDLINE]
	CAR-T cell therapy for pancreatic cancer: Translating emerging targets and dual-targeting strategies from solid tumors. Front Immunol Shen S, Ruan Z, Jiang B, Qiu W, Zhang F, Shu R. PMID: 42039159 [PubMed - indexed for MEDLINE]
	"Treatment Patterns and Survival Outcomes in Periampullary Carcinoma: A Multicentric Retrospective Study from the Indian Subcontinent". Indian J Surg Oncol Sehrawat A, Jayalingappa K, Kumar P, Panda SS, Singhal R, Mohanty SS, Sanyal A, Arumugam N, Rathnam K, Saju SV, Raju HS, Natarajan S, Subhashree S, Selvaraj MK, Sajid M, Gupta A, Sundriyal D. PMID: 42038567 [PubMed]
	A structured, indicator-driven quality improvement cycle is associated with improved adherence and outcomes after liver resection for hepatocellular carcinoma. Front Oncol Xie J, Guo P, Deng Y, Shu H, Du X. PMID: 42038399 [PubMed]
	Establishment and validation of a diagnostic model for evaluating synchronous liver metastasis in pancreatic cancer using comprehensive blood biochemical indicators. Oncol Lett Jiang Y, Peng G, He S, Li J. PMID: 42038344 [PubMed]
	[Solid Pseudopapillary Neoplasm of the Pancreas: Diagnosis and Surgical Management in a Young Patient]. Acta Gastroenterol Latinoam García Alba EL, Chahdi Beltrame M, Ruíz NS, Cervantes G, Lenz Virreira ME, Mattera FJ, Quiñonez EG. PMID: 42038343 [PubMed]
	Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (AISP). Dig Liver Dis Carrara S, Archibugi L, Terrin M, Secchettin E, De Luca R, Paiella S. PMID: 42036279 [PubMed - as supplied by publisher]
	Gemcitabine-loaded nanoparticles for pancreatic cancer: from mechanistic innovations to clinical translation. Int J Pharm Chosdon S, Leharwani M, Alqahtani T, Shmrany HA, Gupta G, Wen Goh K, Sahebkar A, Kesharwani P. PMID: 42035933 [PubMed - as supplied by publisher]
	STING-Activating Nanomedicines in Cancer Immunotherapy: Mechanisms, Design, and Therapeutic Outcomes. Int Immunopharmacol Singhai H, Rehman U, Bukhary DM, Gupta G, Patil UK, Sahebkar A, Kesharwani P. PMID: 42035546 [PubMed - as supplied by publisher]
	Failure of the Galleri multi-cancer detection trial to meet its primary endpoint. Diagnosis (Berl) Diamandis EP. PMID: 42035227 [PubMed - as supplied by publisher]
	The interactions between geriatric nutritional risk index and systemic immune-inflammation index for post-recurrence prognosis in patients with pancreatic cancer: a retrospective study. World J Surg Oncol Sakamoto T, Uehira K, Yoshida J, Kishino M, Morimoto M, Murakami Y, Miyatani K, Shishido Y, Kihara K, Matsunaga T, Yamamoto M, Tokuyasu N, Fujiwara Y. PMID: 42035090 [PubMed - as supplied by publisher]
	A tumor microenvironment integrated (TMI) staging system for pancreatic ductal adenocarcinoma based on cancer-associated fibroblast and molecular consensus signatures. Discov Oncol Yeo SJ, Sim ITEE, Tay HY, Tai D, Shi R, Chan JY. PMID: 42033556 [PubMed - as supplied by publisher]
	The mechanisms and clinical prospects of combining chemotherapy with immunotherapy for advanced pancreatic cancer. Discov Oncol Wolasse Manfouo WQ, Hua Y. PMID: 42032169 [PubMed - as supplied by publisher]
	Supervised (Home-Based Exercise) Prehabilitation Program in Pancreatic Cancer Patients Undergoing to Neoadjuvant Chemotherapy: A Pilot Feasibility Study. Med Sci (Basel) Boccia G, Beratto L, Tarperi C, Rainoldi A, Calliera C, Ierace D, Satolli MA, Bo S, Costelli P. PMID: 42029608 [PubMed - indexed for MEDLINE]
	Investigating machine learning algorithms to classify label-free images of pancreatic neuroendocrine neoplasms. Biophotonics Discov Daigle N, Guan S, Duan S, Knapp TG, Lee EJ, Azhdarinia A, Ghosh SC, AghaAmiri S, Vargas SH, Ikoma N, Estrella J, Schnermann MJ, Else T, Kim MK, Merchant JL, Sawyer TW. PMID: 42028298 [PubMed]
	Human Pancreatic Cancer Organoids. Cell Prolif He A, Lin X, Qian X, Mu J, Tao Z, Gu J, Wang Y, Han T, Zhao H, Wang Y, Zhang J, Zhou Z, Xing L, Zhou C, Zhu D, Liu Z, Chen G, Zhou Q, Wang X, Zhao S, Liu X, Cao D, Yu B, Liu Z, Wang J, Niu G, Wei G, Chen M, Wang W, Kang X, Zhou J, Gong S, Xie Y, Zhang J, Kong X, Dong C, Zou Y, Tang L, Ma A, Xiong H, Liu X, Zhao T, Hao J, Xiao X, Xiang D. PMID: 42026891 [PubMed - as supplied by publisher]

Articles 1 - 20 / 59834

Page 1 de 2992



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité